Frank Carl Grumet

Publications

• Donor-recipient sex mismatch in kidney transplantation. Tan JC, Kim JP, Chertow GM, Grumet FC, Desai M. Gend Med. 2012; 9 (5): 335-347.e2
• Validity of surrogate measures for functional nephron mass. Tan JC, Paik J, Chertow GM, Grumet FC, Busque S, Lapasia J, Desai M. Transplantation. 2011; 92 (12): 1335-41
• H-Y antibody development associates with acute rejection in female patients with male kidney transplants. Tan JC, Wadia PP, Coram M, Grumet FC, Kambham N, Miller K, Pereira S, Vayntrub T, Miklos DB. Transplantation. 2008; 86 (1): 75-81
• Diagnosis of transfusion-related acute lung injury: TRALI or not TRALI? Fontaine MJ, Malone J, Mullins FM, Grumet FC. Ann Clin Lab Sci. 2006; 36 (1): 53-8
• A technique of bone marrow collection from vertebral bodies of cynomolgus macaques for transplant studies. Flores MG, Holm B, Larson MJ, Lau MK, Si MS, Lowsky R, Rousvoal G, Grumet FC, Strober S, Hoppe R, Reitz BA, Borie DC. J Surg Res. 2005; 124 (2): 280-8
• Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose. Cao TM, Shizuru JA, Wong RM, Sheehan K, Laport GG, Stockerl-Goldstein KE, Johnston LJ, Stuart MJ, Grumet FC, Negrin RS, Lowsky R. Blood. 2005; 105 (6): 2300-6
• Protective conditioning for acute graft-versus-host disease. Lowsky R, Takahashi T, Liu YP, Dejbakhsh-Jones S, Grumet FC, Shizuru JA, Laport GG, Stockerl-Goldstein KE, Johnston LJ, Hoppe RT, Bloch DA, Blume KG, Negrin RS, Strober S. N Engl J Med. 2005; 353 (13): 1321-31
• Short tandem repeat analysis to monitor chimerism in macaca fascicularis. Lau M, Vayntrub T, Grumet FC, Lowsky R, Strober S, Hoppe R, Larson M, Holm B, Reitz B, Borie D. Am J Transplant. 2004; 4 (9): 1543-8
• Variable hematopoietic graft rejection and graft-versus-host disease in MHC-matched strains of mice. Cao TM, Lo B, Ranheim EA, Grumet FC, Shizuru JA. Proc Natl Acad Sci U S A. 2003; 100 (20): 11571-6
• Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Millan MT, Shizuru JA, Hoffmann P, Dejbakhsh-Jones S, Scandling JD, Grumet FC, Tan JC, Salvatierra O, Hoppe RT, Strober S. Transplantation. 2002; 73 (9): 1386-91
• Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients. Auffermann-Gretzinger S, Lossos IS, Vayntrub TA, Leong W, Grumet FC, Blume KG, Stockerl-Goldstein KE, Levy R, Shizuru JA. Blood. 2002; 99 (4): 1442-8
• CD31 mismatching affects marrow transplantation outcome. Grumet FC, Hiraki DD, Brown BWM, Zehnder JL, Zacks ES, Draksharapu A, Parnes J, Negrin RS. Biol Blood Marrow Transplant. 2001; 7 (9): 503-12
• Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Mignot E, Lin L, Rogers W, Honda Y, Qiu X, Lin X, Okun M, Hohjoh H, Miki T, Hsu S, Leffell M, Grumet F, Fernandez-Vina M, Honda M, Risch N. Am J Hum Genet. 2001; 68 (3): 686-99
• Concurrent IVF and spontaneous conception resulting in a quadruplet pregnancy. Milki AA, Hinckley MD, Grumet FC, Chitkara U. Hum Reprod. 2001; 16 (11): 2324-6
• Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity. Strober S, Benike C, Krishnaswamy S, Engleman EG, Grumet FC. Transplantation. 2000; 69 (8): 1549-54
• Familial coagulation factor V deficiency caused by a novel 4 base pair insertion in the factor V gene: factor V Stanford [erratum]. Zehnder JL, Hiraki DD, Jones CD, Gross N, Grumet FC. Thromb Haemost. 1999; 82 (5): XII
• Familial coagulation factor V deficiency caused by a novel 4 base pair insertion in the factor V gene: factor V Stanford. Zehnder JL, Hiraki DD, Jones CD, Gross N, Grumet FC. Thromb Haemost. 1999; 82 (3): 1097-9
• Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy. Mignot E, Kimura A, Lattermann A, Lin X, Yasunaga S, Mueller-Eckhardt G, Rattazzi C, Lin L, Guilleminault C, Grumet FC, Mayer G, Dement WC, Underhill P. Tissue Antigens. 1997; 49 (4): 329-41
• HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Mignot E, Hayduk R, Black J, Grumet FC, Guilleminault C. Sleep. 1997; 20 (11): 1012-20
• Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. Suzuki Y, Wong SY, Grumet FC, Fessel J, Montoya JG, Zolopa AR, Portmore A, Schumacher-Perdreau F, Schrappe M, Köppen S, Ruf B, Brown BW, Remington JS. J Infect Dis. 1996; 173 (1): 265-8
• Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease. Behar E, Chao NJ, Hiraki DD, Krishnaswamy S, Brown BW, Zehnder JL, Grumet FC. N Engl J Med. 1996; 334 (5): 286-91
• A new DRB1*1202 allele (DRB1*12022) found in association with DQA1*0102 and DQB1*0602 in two black narcoleptic subjects. Behar E, Lin X, Grumet FC, Mignot E. Immunogenetics. 1995; 41 (1): 52
• Narcolepsy and immunity. Mignot E, Tafti M, Dement WC, Grumet FC. Adv Neuroimmunol. 1995; 5 (1): 23-37
• An immunoglobulin switchlike sequence is linked with canine narcolepsy. Mignot E, Bell RA, Rattazzi C, Lovett M, Grumet FC, Dement WC. Sleep. 1994; 17 (8 Suppl): S68-76
• Bioengineered soluble HLA-B7. Genesis, characterization, and occurrence of dimerization. Hiraki DD, See-Tho K, Filvaroff E, Krishnaswamy S, de Bello W, Taidi-Laskowski B, Grumet FC. Hum Immunol. 1994; 40 (3): 235-46
• Cell surface antigen stability of cultured human umbilical vein vascular endothelial (VEC) cells. Behar E, Bryant P, Taidi-Laskowski B, Kalil J, Grumet FC. Tissue Antigens. 1994; 44 (5): 332-4
• DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. Mignot E, Lin X, Arrigoni J, Macaubas C, Olive F, Hallmayer J, Underhill P, Guilleminault C, Dement WC, Grumet FC. Sleep. 1994; 17 (8 Suppl): S60-7
• Report of the second international soluble HLA (sHLA) workshop. Phoenix, Arizona, October 2, 1993. Grumet FC, Buelow R, Grosse-Wilde H, Kubens B, Garovoy M, Pouletty P. Hum Immunol. 1994; 40 (3): 153-65
• Soluble form of an HLA-B7 class I antigen specifically suppresses humoral alloimmunization. Grumet FC, Krishnaswamy S, See-Tho K, Filvaroff E, Hiraki DD. Hum Immunol. 1994; 40 (3): 228-34
• HLA antibody enhancement by double addition of serum: use in platelet donor selection. Bryant PC, Vayntrub TA, Schrandt HA, Kalil JE, Grumet FC. Transfusion. 1992 Nov-Dec; 32 (9): 839-44
• Genetic linkage of autosomal recessive canine narcolepsy with a mu immunoglobulin heavy-chain switch-like segment. Mignot E, Wang C, Rattazzi C, Gaiser C, Lovett M, Guilleminault C, Dement WC, Grumet FC. Proc Natl Acad Sci U S A. 1991; 88 (8): 3475-8
• Familial patterns of narcolepsy. Guilleminault C, Mignot E, Grumet FC. Lancet. 1989; 2 (8676): 1376-9
• Narcolepsy without unique MHC class II antigen association: studies in the canine model. Dean RR, Kilduff TS, Dement WC, Grumet FC. Hum Immunol. 1989; 25 (1): 27-35
• Secretion of genetically engineered human/mouse class I antigens. Cohen N, Crawford JS, Hiraki DD, Grumet FC. Hum Immunol. 1989; 25 (3): 207-222
• Application of biosafety principles in blood establishments. Grumet FC, MacPherson JL, Hoppe PA, Smallwood LA. Transfusion. 1988 Sep-Oct; 28 (5): 502-5
• Use of RecA protein to enrich for homologous genes in a genomic library. Taidi-Laskowski B, Tyan D, Honigberg SM, Radding CR, Grumet FC. Nucleic Acids Res. 1988; 16 (16): 8157-69
• Human monoclonal antibodies to Rh0(D). Foung SK, Blunt JA, Wu PS, Ahearn P, Winn LC, Engleman EG, Grumet FC. Vox Sang. 1987; 53 (1): 44-7